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SUMMARY. The treatment of adolescents with behavior disorders represents significant challenges. This article reviews some of the most effective
behavioral and pharmacological treatments identified in the research. The
study used outcome data from a residential treatment program to identify variables that predicted level of functioning post-discharge. Significant variables
included diagnosis (mood vs. behavior disorder spectrum), co-morbidity and
discharge placement. [Article copies available for a fee from The Haworth Document

Delivery Service: 1-800-HAWORTH. E-mail address: <getinfo@haworthpressinc.com>
Website: <http://www.HaworthPress.com> © 2002 by The Haworth Press, Inc. All
rights reserved.]
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INTRODUCTION
Adolescents with a diagnosis of conduct disorder represent a significant challenge in assessment and treatment. A multi-agency task force recently reviewed the data from adolescent referrals in the Medicaid

population in the state of Nebraska. Data revealed that the larger spectrum of conduct disorder behaviors accounted for approximately 50% of
clinical referrals. These referrals utilized approximately 63% of the treatment dollars spent during 1999 (Lyons & Leon, 1999). Most of these referrals were for a level of care that necessitated residential treatment.
Conduct Disorder (CD) is a diagnosis that is easy to make and difficult
to treat. In contrast to DSM-III R criteria, DSM-IV criteria allow for
subtyping CD according to age of onset (before or after age 10) and severity (mild, moderate or severe.) The age based amendment reflects empirical findings that show a different co-morbidity profile between childhoodv. adolescent-onset CD. Also, children with childhood-onset CD seem to
have a greater frequency of neuropsychiatric disorders, including low IQ,
ADHD, aggression and familial clustering of externalizing disorders.
There are many studies documenting the extensive comorbidities
found with CD (Loeber & Keenan, 1994; Pfeffer, Klerman, Hurt,
Kakuma, Peskin, & Siefker, 1993; Soltys, Kashani, Dandoy, & Vaidya,
1992). Of the externalizing disorders, ADHD is a common comorbid
condition, along with ODD and substance abuse. Among internalizing
disorders, mood and anxiety disorders are common. Some studies also
show a high frequency of PTSD in confined adolescent males (Burton,
Foy, Bwanuasi, & Johnson, 1994; Steiner, Williams, Benton-Hardy,
Kohler, & Duxbury, 1998).
A thorough multi-dimensional assessment across situations and reporters is necessary to accurately identify CD in adolescence. Self-report
may minimize the problems and omit events that show disturbance
(Bank, Duncan, Patterson, & Reid, 1993; Kazdin, 1992; Luiselli, 1991).
A detailed and comprehensive neuropsychiatric evaluation should be
completed with close attention to the medical history, including accidents, injuries and corresponding deficits and dysfunction. There is wide
agreement in the field that the best treatment of CD is multi-modal which
includes the medical, cognitive, behavioral, educational, family and environmental vulnerabilities of each child.
The literature demonstrates a positive response for comorbid ADHD
symptoms using CNS stimulants. In addition to their effectiveness, they
are well studied, effective and safe when appropriately monitored and
show substantial short term beneficial effects (American Academy of
Child and Adolescent Psychiatry, 1991, 1997; Hinshaw, Buhrmester, &
Heller, 1989; Hinshaw, Heller, & McHale, 1992). There are additional
medication options based on the comorbid condition or specific target
symptoms. These include neuroleptics for paranoia, psychotic ideation
and aggression, although side-effects can potentially outweigh benefits

(Aman, Marks, Turbott, 1991; Campbell, Gonzalez, Ernst, 1992;
Campbell, Gonzalez, & Silva, 1993). Antidepressants, particularly the
SSRI’s, are used to target depressive and anxiety disorders along with
impulsivity. Clonidine and quanfacine are used for hyperarousal symptoms, commonly in tandem with stimulants.
Anti-convulsants or mood stabilizers are used for bipolar disorder and
states of mood lability or severe impulsivity. Sedative and anxiolytics
(especially benzodiazepines and antihistamines) generally showed limited usefulness and their problematic side-effects on memory and cognition, along with abuse potential, precluded any regular therapeutic usage
(Vieselmann, Yaylayan, Weller, 1993).
In looking at the behavioral treatment, it is important to note the research findings regarding the treatment of adolescents with CD. Dishion,
McCord and Poulin (1999) highlight the problems related to the iatrogenic effects that occur in peer-group interventions. Their longitudinal
research showed that the “deviancy training” which happens in long-term
treatment group settings, increases adolescent problem behavior and negative life-time outcomes. Other research has supported the negative influence of deviant peers on the psychosocial development of adolescents
(Patterson, 1993; Elliott, Huizinga & Ageton, 1985).
The research has identified the most effective interventions to treat the
adolescents with a conduct disorder. One of the most effective alternatives identified in the research (Kazdin & Weisz, 1998) appears to be
Multi-Systemic Therapy (MST). MST develops interventions and support
within the family and uses the family/systemic strengths as treatment “levers” to help move and shape the adolescent’s behavior. Other empirically
supported treatments include cognitive-problem-solving skills (Crick &
Dodge, 1994; Spivack & Shure, 1982) and Parent Management Training
(Graziano & Diament, 1992). The cognitive problem-solving skills training (PSST) approach trains youth to identify appropriate, pro-social ways
to achieve their goals, as well as to identify potential negative consequences to their behavior. The Parent Management Training (PMT) helps
parents to attend to appropriate behavior while responding directly and
consistently to disruptive or deviant behavior. All three of these treatment
approaches (MST; PSST and PMT) have been documented as effective
and appropriate treatments for children and adolescents with conduct disorders (Kazdin & Weisz, 1998). Importantly, none of these treatments involve the aggregation of youth with conduct disorder.
Residential treatment level of care is often considered essential for
high-risk adolescents. Residential treatment is required for those adolescents who represent significant risk to themselves or others and who

cannot be maintained in a community setting. Many of these adolescents have a diagnosis within the behavior disorder spectrum. The adolescents within this spectrum present a unique challenge, because the
group environment of a residential program may be at odds with the
concept of family and home interventions that have been identified as
successful strategies in the research.
METHODS
Following the review of the literature we decided to conduct an outcome study that analyzed the outcome of our population according to the
variables suggested in the literature, including diagnosis, comorbidity
and living environment. We were interested in learning whether
post-discharge success (as measured by GAF) was influenced by the
variable of diagnosis type (conduct disorder spectrum vs. mood disorder spectrum), comorbidity (number of diagnoses on discharge) or discharge placement (home, foster care, treatment group home).
Participants
The subject population included 37 males drawn randomly from the
total population of 92 males, who participated in the Residential Treatment Center (RTC) program at Regional West Medical Center
(RWMC) in Scottsbluff, Nebraska during the time period between
June, 1999, to January, 2001. The RTC program at RWMC is a small,
8-bed program in a rural community in western Nebraska. The program
uses a combination of positive peer-culture and a structured behavior
modification program.
The subject population had a wide variety of diagnoses: 17 subjects
had primary mood disorder diagnoses and 20 subjects had primary behavior disorder diagnoses. Comorbidity was high: only 2 subjects had a
single diagnosis; 15 subjects had two diagnoses; 11 had three diagnoses; 4 had four diagnoses; and 5 had five diagnoses.
Discharge placements varied along the continuum of care and included 12 subjects returning to their homes, 13 to a level of care consistent with treatment group homes, 7 to levels of care consistent with
therapeutic foster care, and 5 to other residential treatment centers.
Procedures
Data collection involved contacting the caregivers of a cross-section
of our treatment population (n = 37) to identify the adolescent’s level of

functioning at 6 to 12 months post-discharge. A variety of people performed the role of caregiver and included parents, case-managers, therapists, and other program staff according to discharge placement. The
contact was made by telephone by either a clinical psychologist or master’s degree level intern using the same protocol. The length of time
post-discharge varied between 6 and 12 months with a mean of 8.1
months post-discharge.
Measures
The diagnoses were made by the Medical Director of the RTC program at RWMC after an initial 2-week assessment and observation period, with input from a multi-disciplinary team. Diagnoses that had
“rule-out” status were not included. The Global Assessment of Functioning score was used to assess overall functioning. This measure provided a “common language” across providers to assess functioning in a
wide variety of domains, including home, school and social. The protocol
prompted the caregiver to consider functioning across all domains.
RESULTS
We found that the three variables of diagnosis type (conduct disorder
spectrum vs. mood disorder spectrum), comorbidity and discharge placement all contributed to a significant part of the variance when predicting
GAF at post discharge follow-up. When we compared the data between
those residents with a conduct disorder spectrum diagnosis with those
given a mood disorder spectrum diagnosis, we found a significant difference in their success rates (F(2, 35) = 22.06 p < .0001). Adolescents with
a primary mood disorder were functioning at a significantly higher level
than those with a primary behavior disorder.
Our data also indicated significant negative correlation between
comorbidity and post discharge success (Figure 1). Again, the effect was
greater for those adolescents with the conduct disorder spectrum (F =
(1,35) 26.63 < .0001.) Discharge placement was the third variable that
contributed a significant part of the GAF variance on follow-up. The majority of our residents were discharged to treatment group home level of
care. However, those residents that were discharged to either home or
treatment foster care had significantly higher GAF scores at follow-up.
When we analyzed all variables in a simultaneous regression, the three
variables accounted for 63% of the variance of GAF outcome (R = .815,

FIGURE 1. GAF Scores as a Function of Number of Comorbid Diagnoses
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R2 = .664, SE = 7.53. Diagnosis B = ⫺9.75, SE = 2.75; Discharge placement B = ⫺2.97, SE = 1.10; Comorbid B = ⫺4.55, SE 1.29).
DISCUSSION
In discussing our results, we expected that those residents with a primary mood disorder would function at a higher level than those with
primary conduct disorder spectrum diagnosis. The results of the follow-up data indicated that this was an accurate prediction. Adolescents
with conduct disorder spectrum may be more treatment resistant, evoke
negative responses from peers and caregivers and negatively affect
their level of functioning. We also predicted that comorbidity would
negatively affect adjustment. Our results also supported that predication. The multiple diagnoses and complex symptom picture of many of
our adolescents interfered with their ability to acquire the behavioral

skills and emotion management that is required in step-down placements.
However, the effect that discharge placement had on the functioning
level of these adolescents was unexpected. Adolescents with conduct
disorder spectrum diagnoses showed a lower level of functioning when placed
in group home environments than in foster or family-home environments.
The data from our small program appears to be consistent with the review of the literature that indicates that a home environment is the best
placement in which treatment can occur for an adolescent with a primary
or secondary diagnosis of conduct disorder. The reason for that success
may be the lack of “deviancy training” or it may be the development of
wrap-around services that are anchored to a home environment. However, there is a secondary benefit to RTC programs, as they then are able
to treat their adolescent populations without the effect of “deviancy training” by the conduct disordered adolescents. Thus, the axiom of “there’s
no place like home” is often true for many reasons.
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